Secukinumab can treat psoriasis induced by anti-TNF-alpha therapy in patients with ankylosing spondylitis: Case series.

MLA

Apaydin, Hakan, et al. “Secukinumab Can Treat Psoriasis Induced by Anti-TNF-Alpha Therapy in Patients with Ankylosing Spondylitis: Case Series.” International Journal of Rheumatic Diseases, vol. 23, no. 3, Mar. 2020, pp. 454–56. EBSCOhost, https://doi.org/10.1111/1756-185X.13791.

APA

Apaydin, H., Dogan, I., & Erten, Ş. (2020). Secukinumab can treat psoriasis induced by anti-TNF-alpha therapy in patients with ankylosing spondylitis: Case series. International Journal of Rheumatic Diseases, 23(3), 454–456. https://doi.org/10.1111/1756-185X.13791

Chicago

Apaydin, Hakan, Ismail Dogan, and Şükran Erten. 2020. “Secukinumab Can Treat Psoriasis Induced by Anti-TNF-Alpha Therapy in Patients with Ankylosing Spondylitis: Case Series.” International Journal of Rheumatic Diseases 23 (3): 454–56. doi:10.1111/1756-185X.13791.